Doorley B M, Knight V V, Spaulding T C
Department of Pharmacology, Anaquest/BOC Health Care, Murray Hill, New Jersey 07974.
Life Sci. 1988;43(4):365-72. doi: 10.1016/0024-3205(88)90114-2.
The cardiovascular and respiratory effects of alfentanil in conscious freely moving rats, were evaluated after initial and subsequent injections. Doses of alfentanil (50, 130, 260, and 500 ug/kg) were given to naive rats (n = 4-5) and 1 hour later this dose was repeated. The resultant cardiovascular and respiratory effects were compared. At all doses there was a significant (p less than 0.05) depression of mean arterial pressure and heart rate after the initial dose of alfentanil. At doses of 50, 130, and 260 ug/kg, the second administration elicited significantly less depression of cardiovascular parameters than the initial dose. Maximum changes in respiratory parameters (PaCO2 and PaO2) were also significantly less after the second administration of alfentanil. This difference, in maximum respiratory depression, was not seen at the highest doses (500 ug/kg). These results indicate that tolerance, to the cardiorespiratory side effects seen after alfentanil, can occur in as little as 1 hour after subsequent bolus injections.
在初次注射及后续注射后,对清醒自由活动大鼠中阿芬太尼的心血管和呼吸效应进行了评估。将阿芬太尼剂量(50、130、260和500微克/千克)给予未经处理的大鼠(n = 4 - 5),1小时后重复该剂量。比较由此产生的心血管和呼吸效应。在初次给予阿芬太尼后,所有剂量均使平均动脉压和心率出现显著(p < 0.05)下降。在50、130和260微克/千克剂量下,第二次给药引起的心血管参数下降明显低于初次给药。第二次给予阿芬太尼后,呼吸参数(PaCO2和PaO2)的最大变化也显著更小。在最高剂量(500微克/千克)下,未观察到最大呼吸抑制方面的这种差异。这些结果表明,在后续推注给药后仅1小时,即可出现对阿芬太尼后所见心肺副作用的耐受性。